Share

August 07, 2012; 79 (6) Clinical/Scientific Notes

Relapsing course of Immunoglobulin G4-related pachymeningitis

Kevin A. Shapiro, Riley M. Bové, Elgida R. Volpicelli, Robert M. Mallery, John H. Stone
First published July 25, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31826356fc
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
267

Share

Article Information

vol. 79 no. 6 604-606
DOI: 
https://doi.org/10.1212/WNL.0b013e31826356fc
PubMed: 
22843267
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 31, 2011
  • Accepted February 29, 2012
  • First Published July 25, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Kevin A. Shapiro, MD, PhD,
    2. Riley M. Bové, MD,
    3. Elgida R. Volpicelli, MD,
    4. Robert M. Mallery, MD and
    5. John H. Stone, MD, MPH
  1. Kevin A. Shapiro, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Children’s Hospital Boston

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Riley M. Bové, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH T32 training grant. Role: mentee. PI: George Tsokos, PhD, Harvard Medical School. Dates: 5/11-5/12

    Research Support, Academic Entities:

    1. Partners Healthcare. Salary for residency training (7/2007-9/2011). Brigham and Women’s Hospital BWPH. Clinical staff (9/2011- ongoing).

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Elgida R. Volpicelli, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Robert M. Mallery, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. John H. Stone, MD, MPH
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Roche Genentech

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. A Clinician’s Pearls & Myths in Rheumatology, Springer, 2010 Current Diagnosis & Treatment in Rheumatology, McGraw-Hill 2006-12 Sjogren’s syndrome, Springer, 2012

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Roche Genentech

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Genentech Biogen-IDEC Genzyme

    Research Support, Government Entities:

    1. National Institutes of Health/National Institute of Arthritis, Musculoskeletal, and Skin Diseases, 2011-2

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (K.A.S., R.M.B., R.M.M.) and Medicine (J.H.S.), Rheumatology Unit, Massachusetts General Hospital; and Departments of Neurology (K.A.S., R.M.B., R.M.M.) and Pathology (E.R.V.), Brigham and Women's Hospital, Boston, MA.
  1. Correspondence & reprint requests to Dr. Stone: jhstone{at}partners.org
View Full Text

Article usage

Article usage: July 2012 to May 2023

AbstractFullPdfSource
Jul 201234010Highwire
Aug 20123957469Highwire
Sep 2012682116Highwire
Oct 201274315Highwire
Nov 2012033Highwire
Dec 2012086Highwire
Jan 20130611Highwire
Feb 2013047Highwire
Mar 2013099Highwire
Apr 20130125Highwire
May 2013082Highwire
Jun 20132566Highwire
Jul 20134221Highwire
Aug 20133732Highwire
Sep 20135443Highwire
Oct 20134211Highwire
Nov 201314210Highwire
Dec 20132142Highwire
Jan 20142500Highwire
Feb 20142332Highwire
Mar 20141812Highwire
Apr 20142600Highwire
May 20141802Highwire
Jun 20142800Highwire
Jul 20142133Highwire
Aug 2014701Highwire
Sep 20142601Highwire
Oct 20141510Highwire
Nov 20141814Highwire
Dec 2014911Highwire
Jan 20151023Highwire
Feb 20151212Highwire
Mar 20151013Highwire
Apr 2015903Highwire
May 20152200Highwire
Jun 20151311Highwire
Jul 20152121Highwire
Aug 20152432Highwire
Sep 20152201Highwire
Oct 20153635Highwire
Nov 20151541Highwire
Dec 20152801Highwire
Jan 20161511Highwire
Feb 20161223Highwire
Mar 20161500Highwire
Apr 20161233Highwire
May 20161421Highwire
Jun 20162100Highwire
Jul 20162422Highwire
Aug 20161712Highwire
Sep 20162200Highwire
Oct 20162101Highwire
Nov 20161422Highwire
Dec 20161901Highwire
Jan 20172200Highwire
Feb 20171511Highwire
Mar 20171300Highwire
Apr 20172110Highwire
May 2017400Highwire
Jun 20171301Highwire
Jul 2017610Highwire
Aug 20171912Highwire
Sep 20171000Highwire
Oct 20171521Highwire
Nov 20171120Highwire
Dec 2017600Highwire
Jan 20181700Highwire
Feb 2018801Highwire
Mar 20181601Highwire
Apr 20181200Highwire
May 2018802Highwire
Jun 20181800Highwire
Jul 2018600Highwire
Aug 20181000Highwire
Sep 20181800Highwire
Oct 20183210Highwire
Nov 20183421Highwire
Dec 20183911Highwire
Jan 20193100Highwire
Feb 20192800Highwire
Mar 20193800Highwire
Apr 20193301Highwire
May 20191100Highwire
Jun 20191434Highwire
Jul 2019301Highwire
Aug 2019200Highwire
Sep 2019500Highwire
Oct 20191700Highwire
Nov 20191000Highwire
Dec 2019410Highwire
Jan 2020911Highwire
Feb 20201100Highwire
Mar 2020600Highwire
Apr 2020310Highwire
May 2020801Highwire
Jun 20202000Highwire
Jul 2020911Highwire
Aug 20201442Highwire
Sep 2020710Highwire
Oct 20201710Highwire
Nov 20201410Highwire
Dec 2020710Highwire
Jan 2021621Highwire
Feb 2021800Highwire
Mar 20212301Highwire
Apr 20211111Highwire
May 20211021Highwire
Jun 2021600Highwire
Jul 20211200Highwire
Aug 20211010Highwire
Sep 2021511Highwire
Oct 20211002Highwire
Nov 20211200Highwire
Dec 20211710Highwire
Jan 2022400Highwire
Feb 20221301Highwire
Mar 20221500Highwire
Apr 20222012Highwire
May 2022910Highwire
Jun 2022500Highwire
Jul 20221011Highwire
Aug 2022600Highwire
Sep 2022900Highwire
Oct 20221121Highwire
Nov 20221100Highwire
Dec 20221300Highwire
Jan 20231200Highwire
Feb 2023400Highwire
Mar 2023700Highwire
Apr 2023900Highwire
May 2023900Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles